title: Managing severe behavioral symptoms of a patient with anti-NMDAR encephalitis: case report and findings in current literature.
abstract: OBJECTIVE
  Psychiatric symptoms emerge in the early stages of anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, and patients often seek treatment in psychiatric departments before visiting any other general medical services. Numerous articles about anti-NMDAR encephalitis have been published in the scientific community worldwide, but few emphasize the role of psychiatry in symptom management.
  
  
  METHODS
  We describe the case of a patient with anti- -NMDAR encephalitis seen in our service and discuss the management of behavioral symptoms based on current scientific literature. High doses of atypical antipsychotics and benzodiazepines were used to control agitation, and trazodone was administered to treat insomnia.
  
  
  CONCLUSIONS
  Consultation-liaison psychiatry may help the healthcare team adjust the management of neuropsychiatric complications that might affect inpatients with anti-NMDAR encephalitis.
authors: Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
authors: Vanina Lima
authors: VL
authors: Monteiro
authors: Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
authors: Felipe José Nascimento
authors: FJ
authors: Barreto
authors: Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
authors: Paulo Marcos Brasil
authors: PM
authors: Rocha
authors: Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
authors: Paulo Henrique Teixeira
authors: PH
authors: do Prado
authors: Mental Health Department, UFMG, Belo Horizonte, MG, Brazil.
authors: Frederico Duarte
authors: FD
authors: Garcia
authors: Mental Health Department, UFMG, Belo Horizonte, MG, Brazil.
authors: Humberto
authors: H
authors: Correa
authors: Mental Health Department, UFMG, Belo Horizonte, MG, Brazil.
authors: Maila Castro Lourenço
authors: MC
authors: das Neves
mesh_terms: D000328:Adult; D060426:Anti-N-Methyl-D-Aspartate Receptor Encephalitis / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology*; D006801:Humans; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy / Q000503:physiopathology; D011619:Psychotropic Drugs / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D011619:Psychotropic Drugs